Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rifampin-combined Antibiotic Therapy for Staphylococcal PJI
NCT07313215Recruiting
- Sponsor
- The First Hospital of Fujian Medical University
- Start
- Nov 2025
- Primary completion
- Jun 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of rifampicin in periprosthetic joint infection (PJI) (2 arms), sponsored by The First Hospital of Fujian Medical University. Primary endpoints: Clearance rate of infection at 2 years and Adverse events related to PJI at 2 years. Started Nov 2025; status: recruiting.
02
Drugs
rifampicin
03
Conditions
periprosthetic joint infection (PJI)
Beyond the preview
Go deeper on NCT07313215.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07313215.